• No results found

University of Groningen The long road Hilgendorf, Susan

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen The long road Hilgendorf, Susan"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

The long road

Hilgendorf, Susan

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Hilgendorf, S. (2018). The long road: The autophagic network and TP53/ASXL1 aberrations in hematopoietic malignancies. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

STELLINGEN

1. In mouse models, ASXL1 loss needs an additional genetic aberration to promote myeloid malignancies – Abdel-Wahab (Cancer Cell 2012); Abdel-Wahab (JEM 2013)

2. Expression of ASXL1 mutations rather than knockdown of ASXL1 may lead to transformation in xenografts – Inoue (J Clin Invest 2013), Inoue (JEM 2018), this thesis

3. AMLs with TP53 mutations reveal a higher autophagic flux than other AMLs – this thesis

4. Cancer cells can make use of autophagy to become treatment resistant – this thesis

5. TP53 mutations may use their gain-of-function activity to target chromatin regulators and to drive growth of cancer – Zhu (Nature 2015)

6. Treatment of patients can influence clonal evolution – Wong (Blood 2016); Silva-Coelho (Nat Commun 2017); Berger (Blood 2018)

7. “Nur die Harten kommen in den Garten” (only the strongest survive) – my mother

8. “You don’t want to publish porridge” – Peter Doherty 9. Negative results are results – this thesis

10. “I don’t know where I am going, but I am on my way” – Carl Sagan

Referenties

GERELATEERDE DOCUMENTEN

However, event complexity aside, empirical arguments for 1a can be developed, if we consider a third form, the middle, which, as is well known, does have causative-transitive

TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation. Sallman DA,

Knockdown of ASXL1 leads to loss of H3K27me3 during erythroid but not myeloid progenitor development+. To investigate whether the observed phenotypes could be attributed to changes

On day 24, cells with a double knockdown had similar cumulative cell count to control cells and a significantly higher cell count than ASXL1 single cells (p<0.05)... TP53

(A) Left panel: table showing relative expression of ATG5, ATG7 or p53 as determined by q-PCR in shSCR, shATG5, shATG7 and shP53 transduced cell lines or right panel: p53 protein

Another pathway involved in autophagy-mediated resistance to therapy is the MAPK pathway, with chemotherapeutic treatment of hepatocellular carcinoma cell lines leading to increased

Poor-risk AMLs are often associated with TP53 mutations but knockdown or overexpression of wild-type or mutant TP53 did not affect the flux.. When using hydoxychloroquine (HCQ),

Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment..